InvestorsHub Logo
icon url

Pineywoods

12/08/18 9:46 PM

#164116 RE: mtoronto #164112

I like the way you think my friend. I am of the same opinion.
icon url

yankee55

12/08/18 10:34 PM

#164117 RE: mtoronto #164112

The best days to come.....enjoy!!!
icon url

User_347763

12/09/18 2:42 AM

#164123 RE: mtoronto #164112

Investors can read what Andy is saying but can they read what Andy is doing? Know the two and know the difference.



What investors can read is the result of what he is doing in terms of years of declining sales and declining pps. Know the 3 and know the difference.
icon url

User_347763

12/09/18 2:51 AM

#164124 RE: mtoronto #164112

1) 510K resubmission
2) Meeting with the FDA
3) Last but not least, communications through e-mails and telephone conversations may also clear the product.

The NSE was based on the evidence that was submitted in the 510K.



Does this mean the rejection is not final yet?
icon url

White_Knight

12/09/18 4:44 AM

#164126 RE: mtoronto #164112

Thanks for your message Mtoronto, much appreciated!
icon url

Mr Positive

12/09/18 10:40 AM

#164141 RE: mtoronto #164112

Agreed 100%. We too have to remember that the PPS of this OTC stock is heavily controlled by MM's. I an not insinuating that this is good or bad. It is what it is. Upon a press release stating OTC clearance of the reclassification, I fully anticipate at a minimum copperland.
icon url

DewmBoom

12/09/18 11:27 AM

#164144 RE: mtoronto #164112

All talks and execuses for delays. Yo don’t get clearance with the FDA because it is cool, but rather something that is going to translate to sale and deal making. This current CEO does not know who to do that. He needs to step aside as he is the MAIN PROBLEM for the company business success.

We got the foot clearance almost two years ago. It took the clearance another year and a half to happen. Now we are talking 3.5 years of preparation with nothing on the business side. Same thing on the knee side as well.

As for the 510K on ALLAY and post operative, they are nothing but delay tactic to mislead investors.


a. We need BIEL to focus on product sale
b. We need a new CEO who know how to run companies to lead company

Without the above, it is going to be business as usual. Dilution for nothing.
icon url

toohot

04/13/19 11:50 AM

#177580 RE: mtoronto #164112

It’s always refreshing to read the stickie above.
When the FDA announces FULL clearance,
boom goes the dynamite.
I am hoping this occurs this coming Tuesday!

Posters may be wondering why the stock price is not .04 cents with all that’s going on with the company. I can tell you with certainty and without doubt that upon a press release coming out stating OTC clearance of ActiPatch, 510K in FDA possession for postoperative pain, mentioning a partner and or the buyer of certain orders. I believe that the stock price will be higher than stated above.

icon url

toohot

04/28/19 11:55 AM

#178977 RE: mtoronto #164112

Still looking at the prophecy of mtoronto.
Newbies, it’s going to happen.
Welcome to the BIEL family!


Posters may be wondering why the stock price is not .04 cents with all that’s going on with the company. I can tell you with certainty and without doubt that upon a press release coming out stating OTC clearance of ActiPatch, 510K in FDA possession for postoperative pain, mentioning a partner and or the buyer of certain orders. I believe that the stock price will be higher than stated above.

icon url

User_347763

05/26/19 6:21 AM

#182068 RE: mtoronto #164112

Wondering whether you are still defending Whelan and the Whelan next in line.
If you are not sure no need to answer...